Harbour Antibodies BV
Harbour Antibodies BV, a leading player in the biotechnology sector, is headquartered in the Netherlands and operates extensively across Europe and North America. Founded in 2011, the company has established itself as a pioneer in the development of innovative antibody-based solutions for research and therapeutic applications. Specialising in custom monoclonal antibodies, Harbour Antibodies offers unique services that include the generation of high-affinity antibodies tailored to specific targets. Their proprietary technologies and commitment to quality have positioned them as a trusted partner in the life sciences industry. With a strong focus on advancing antibody engineering, Harbour Antibodies BV has achieved significant milestones, including collaborations with prominent research institutions and biopharmaceutical companies, solidifying its reputation as a key contributor to the field of immunology.
DitchCarbon Score
How does Harbour Antibodies BV's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Harbour Antibodies BV's score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Harbour Antibodies BV's reported carbon emissions
Harbour Antibodies BV, headquartered in the Netherlands, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the absence of specific initiatives or targets, it is essential to consider the broader industry context, where many companies are increasingly focusing on sustainability and reducing greenhouse gas emissions. As the landscape evolves, Harbour Antibodies BV may develop and disclose its climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Harbour Antibodies BV is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
